Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
Press Releases
Sep 28, 2022

Visit Covalon to learn how new compassionate care technology is protecting patients from infections, while strengthening patient-centered care. MISSISSAUGA, ON, Sept. 28, 2022 /CNW/ - Covalon...

Sep 26, 2022

Book an appointment with us and visit booth 607 at the Minneapolis Convention Center from September 30 to October 2 to learn more MISSISSAUGA, ON, Sept. 26, 2022 /CNW/ - Covalon Technologies Ltd....

Sep 20, 2022

Advanced post-operative dressing is now used to prevent post-operative infections in patients with congenital heart conditions from birth through adulthood. MISSISSAUGA, ON, Sept. 20, 2022 /CNW/ -...

View All

Email Alerts
* Required Fields
Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com

To contact the Board of Directors to provide comments, report concerns, or ask a question, please contact Amir Boloor (Chair of the Board).
e-mail: aboloor@covalon.com


Contact Form